Public Health Emergency Medical Countermeasures Enterprise

Dear Dr. Coller,

The Biotechnology Industry Organization (BIO) appreciates the opportunity yo provide comments to the Department of Health and Human Services (HHS) on the draft Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Strategy for Chemical, Biological, Radiological and Nuclear (CBRN) Threats. We applaud the Department's efforts and commitment to develop a strategy, as well as the efforts in the recent BioShield Stakeholders Workshop September 25-26, 2006. We also applaud the recognition of the importance and need to clearly identify the government's medical countermeasure acquisition plans and to provide clarity and transparency to the processes by which those plans are determined and fulfilled. We provide the following comments for your consideration, and look forward to continued dialogue on the public-private partnerships for national preparedness.